GALNT6 localization is associated with gland-forming architecture and morphological differentiation in luminal A breast cancer
- 1 July 2026
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1870 (10) , 130975
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 32 references indexed in Scilit:
- Challenges and prospects in HER2-positive breast cancer-targeted therapyCritical Reviews in Oncology/Hematology, 2025
- The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwideInternational Journal of Cancer, 2024
- Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020Cancer Communications, 2021
- Endocrine therapy resistance: new insightsThe Breast, 2019
- Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer CellsNeoplasia, 2018
- Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 KnockdownNeoplasia, 2016
- Adhesion in Mammary Development2015
- PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer CellsCancer Cell, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The importance of MUC1 cellular localization in patients with breast carcinomaCancer, 2001